Breaking News

Adma Biologics Launches COVID-19 Assay

Detects SARS-CoV-2 neutralizing antibodies in plasma.

By: Contract Pharma

Contract Pharma Staff

Adma Biologics Inc., an end-to-end commercial biopharmaceutical company, has launched COVID-19 ImmunoRank Neutralization MICRO-ELISA, a proprietary, fully-validated ELISA assay for the detection of SARS-CoV-2 neutralizing antibodies in plasma.   ImmunoRank, which was developed in collaboration with Leinco Technologies Inc., is intended for use as an aid to identify individuals who produce an adaptive immune response to SARS-CoV-2, indicating recent or prior infection, and specifically for the de...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters